Patients from the control group will receive usual treatment and care. After hospital discharge patients assigned to the control care continue to receive routine management by the cardiologist, and, subsequently, their general practitioner. No extra follow-up by a HF nurse or a multidisciplinary team is provided. Patients in the intervention group 1 (A&Cb ) will receive extra visits to outpatient clinic where they will visit the HF nurse. Education according to guidelines starts during hospital
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. Hospital admission for symptomatic chronic heart failure, established by the cardiologist; 2. Evidence for structural underlying heart disease; 3. >18 years of age.
Exclusion criteria
Exclusion criteria: 1. Are included in medical trials requiring additional visits to research health care personnel; 2. Restrictions that render the patient unable to fill in the data collection materials; 3. Have undergone cardiac invasive intervention the last 6 months (PTCA, CABG, HTC, valve replacement) or planned to have such an procedure the following 3 months; 4. Are evaluated for Heart Transplantation.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of readmissions; 2. Quality of life; 3. Costs; 4. Coompliance; 5. Knowledge; 6. Attitude; 7. Skills; 8. Self-care behaviours. | — |
Primary
| Measure | Time frame |
|---|---|
| Time to first event (HF readmission and death). | — |
Contacts
University Medical Center Groningen (UMCG), Department of Cardiology, P.O. Box 30.001